Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 11:47:47 UTC
Update Date2021-09-26 23:06:32 UTC
HMDB IDHMDB0253377
Secondary Accession NumbersNone
Metabolite Identification
Common NameIdelalisib
DescriptionIdelalisib belongs to the class of organic compounds known as 6-alkylaminopurines. 6-alkylaminopurines are compounds that contain an alkylamine group attached at the 6-position of a purine. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring. Based on a literature review a significant number of articles have been published on Idelalisib. This compound has been identified in human blood as reported by (PMID: 31557052 ). Idelalisib is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically Idelalisib is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC22H18FN7O
Average Molecular Weight415.432
Monoisotopic Molecular Weight415.155686391
IUPAC Name5-fluoro-3-phenyl-2-{1-[(7H-purin-6-yl)amino]propyl}-3,4-dihydroquinazolin-4-one
Traditional Name5-fluoro-3-phenyl-2-[1-(7H-purin-6-ylamino)propyl]quinazolin-4-one
CAS Registry NumberNot Available
SMILES
CCC(NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C1
InChI Identifier
InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)
InChI KeyIFSDAJWBUCMOAH-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 6-alkylaminopurines. 6-Alkylaminopurines are compounds that contain an alkylamine group attached at the 6-position of a purine. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassImidazopyrimidines
Sub ClassPurines and purine derivatives
Direct Parent6-alkylaminopurines
Alternative Parents
Substituents
  • 6-alkylaminopurine
  • Quinazoline
  • Aminopyrimidine
  • Pyrimidone
  • Aryl fluoride
  • Aryl halide
  • Monocyclic benzene moiety
  • Pyrimidine
  • Benzenoid
  • Imidolactam
  • Imidazole
  • Azole
  • Vinylogous halide
  • Heteroaromatic compound
  • Lactam
  • Azacycle
  • Organic oxide
  • Organic oxygen compound
  • Amine
  • Organooxygen compound
  • Organonitrogen compound
  • Organofluoride
  • Organohalogen compound
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3ALOGPS
logP3.32ChemAxon
logS-4.2ALOGPS
pKa (Strongest Acidic)10.19ChemAxon
pKa (Strongest Basic)2.73ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count6ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area99.16 ŲChemAxon
Rotatable Bond Count5ChemAxon
Refractivity118.45 m³·mol⁻¹ChemAxon
Polarizability41.05 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M+H]+191.32230932474
DeepCCS[M-H]-188.92730932474
DeepCCS[M-2H]-222.16330932474
DeepCCS[M+Na]+197.23530932474
AllCCS[M+H]+198.432859911
AllCCS[M+H-H2O]+195.932859911
AllCCS[M+NH4]+200.732859911
AllCCS[M+Na]+201.432859911
AllCCS[M-H]-194.032859911
AllCCS[M+Na-2H]-193.432859911
AllCCS[M+HCOO]-192.832859911

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
IdelalisibCCC(NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C14404.1Standard polar33892256
IdelalisibCCC(NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C13685.4Standard non polar33892256
IdelalisibCCC(NC1=NC=NC2=C1NC=N2)C1=NC2=C(C(F)=CC=C2)C(=O)N1C1=CC=CC=C13831.6Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
Idelalisib,1TMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C3675.8Semi standard non polar33892256
Idelalisib,1TMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C3255.8Standard non polar33892256
Idelalisib,1TMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C4900.1Standard polar33892256
Idelalisib,1TMS,isomer #2CCC(NC1=NC=NC2=C1N([Si](C)(C)C)C=N2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C13754.1Semi standard non polar33892256
Idelalisib,1TMS,isomer #2CCC(NC1=NC=NC2=C1N([Si](C)(C)C)C=N2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C13215.5Standard non polar33892256
Idelalisib,1TMS,isomer #2CCC(NC1=NC=NC2=C1N([Si](C)(C)C)C=N2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C14964.8Standard polar33892256
Idelalisib,2TMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1N([Si](C)(C)C)C=N2)[Si](C)(C)C3723.4Semi standard non polar33892256
Idelalisib,2TMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1N([Si](C)(C)C)C=N2)[Si](C)(C)C3050.7Standard non polar33892256
Idelalisib,2TMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1N([Si](C)(C)C)C=N2)[Si](C)(C)C4534.0Standard polar33892256
Idelalisib,1TBDMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C(C)(C)C3832.7Semi standard non polar33892256
Idelalisib,1TBDMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C(C)(C)C3458.7Standard non polar33892256
Idelalisib,1TBDMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1[NH]C=N2)[Si](C)(C)C(C)(C)C4904.3Standard polar33892256
Idelalisib,1TBDMS,isomer #2CCC(NC1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C13912.0Semi standard non polar33892256
Idelalisib,1TBDMS,isomer #2CCC(NC1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C13391.8Standard non polar33892256
Idelalisib,1TBDMS,isomer #2CCC(NC1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C14992.2Standard polar33892256
Idelalisib,2TBDMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C4065.4Semi standard non polar33892256
Idelalisib,2TBDMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C3606.9Standard non polar33892256
Idelalisib,2TBDMS,isomer #1CCC(C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1)N(C1=NC=NC2=C1N([Si](C)(C)C(C)(C)C)C=N2)[Si](C)(C)C(C)(C)C4620.6Standard polar33892256
Spectra

GC-MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted GC-MSPredicted GC-MS Spectrum - Idelalisib GC-MS (Non-derivatized) - 70eV, Positivesplash10-000i-1639000000-61209f1c436d3ab9d2cc2021-09-24Wishart LabView Spectrum
Predicted GC-MSPredicted GC-MS Spectrum - Idelalisib GC-MS (Non-derivatized) - 70eV, PositiveNot Available2021-10-12Wishart LabView Spectrum

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Idelalisib 10V, Positive-QTOFsplash10-014i-0000900000-93bb13a3d435232623332021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Idelalisib 20V, Positive-QTOFsplash10-014i-0000900000-787119136d4b7823f3322021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Idelalisib 40V, Positive-QTOFsplash10-05n4-2943000000-947118292747c3da4b122021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Idelalisib 10V, Negative-QTOFsplash10-03di-0000900000-517c24087e99c36a6a252021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Idelalisib 20V, Negative-QTOFsplash10-03di-0206900000-896ef6a33366bac7b4b22021-10-12Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Idelalisib 40V, Negative-QTOFsplash10-000f-7593100000-b3981d1e054902c294a42021-10-12Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID9829304
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkIdelalisib
METLIN IDNot Available
PubChem Compound11654566
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]